LON:OBI Ondine Biomedical (OBI) Share Price, News & Analysis → Estee Lauder, MAC, and other beauty brands are raving about this emerging NYSE AI company (From Financial Markets Daily) (Ad) Free OBI Stock Alerts GBX 7.50 0.00 (0.00%) (As of 06/12/2024 ET) Add Compare Share Share Today's Range 7.17▼ 7.7250-Day Range 5.01▼ 9.2552-Week Range 4.50▼ 17Volume75,800 shsAverage Volume311,393 shsMarket Capitalization£20.80 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsHeadlinesStock AnalysisChartCompetitorsHeadlines Get Ondine Biomedical alerts: Email Address Ad Financial Markets DailyEstee Lauder, MAC, and other beauty brands are raving about this emerging NYSE AI companyA Little-known NYSE Company is Empowering the Beauty Industry with Innovative AI and AR Tools.Discover this unknown NYSE Tech SaaS company About Ondine Biomedical Stock (LON:OBI)Ondine Biomedical Inc., a Life sciences company, engages in the research, development, and commercialization of antimicrobial photodisinfection therapies in Canada and internationally. Its product platform is Photodisinfection, a topical light-based antimicrobial technology that eliminates harmful pathogens. The company's lead product is Steriwave, a photodisinfection-based medical device that eliminates harmful nasal pathogens, which leads to healthcare-associated infections. Its product pipeline also includes development of a topical antiviral therapy for the upper respiratory tract that reduces viral titres and transmission of respiratory viruses, such as SARS-CoV-2, influenza, RSV, etc.; a solution for treatment of chronic rhinosinusitis; a solution for disinfection of endotracheal tubes to reduce the incidence of ventilator-associated pneumonia; and a solution for decolonization of burns and wounds. The company was incorporated in 1996 and is headquartered in Vancouver, Canada.Read More OBI Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart OBI Stock News HeadlinesJune 9, 2024 | americanbankingnews.comOndine Biomedical (LON:OBI) Stock Price Down 15.2%May 28, 2024 | uk.finance.yahoo.comOndine Biomedical Inc Announces Notice of Results, Investor Presentation, and AGMApril 25, 2024 | uk.finance.yahoo.comOndine Biomedical Inc Announces New Study Confirms Nose Is Key Source of InfectionApril 24, 2024 | uk.finance.yahoo.comOndine Biomedical Inc Announces Corporate and Trading UpdateApril 22, 2024 | uk.finance.yahoo.comOndine Biomedical Inc Announces Steriwave in First Australian HospitalApril 15, 2024 | uk.finance.yahoo.comOndine Biomedical Inc. Announces 32% Fewer SSIs After Steriwave Replaced MupirocinApril 10, 2024 | uk.finance.yahoo.comOndine Biomedical Inc. Announces Steriwave Authorized for use by HCA UKApril 4, 2024 | uk.finance.yahoo.comOndine Biomedical Inc. Announces Entry into ICU Market Expands Revenue PotentialMarch 27, 2024 | finance.yahoo.comOndine Biomedical achieves milestone with NHS trust's adoption of SteriwaveMarch 25, 2024 | uk.finance.yahoo.comOndine Biomedical Inc. Announces First commercial adoption of Steriwave by the NHSFebruary 1, 2024 | lse.co.ukOndine Biomedical touts efficacy of Steriwave post presenting researchJanuary 27, 2024 | lse.co.ukOndine Biomed Share ChatDecember 5, 2023 | proactiveinvestors.comOndine secures £2.75m of new fundingNovember 16, 2023 | uk.movies.yahoo.comOndine Biomedical Inc Announces Photodisinfection Recommended as Standard of CareNovember 13, 2023 | finance.yahoo.comOndine Biomedical’s nasal photodisinfection named as leading photonics biomedical technology for its potential to safely combat AMRNovember 9, 2023 | uk.finance.yahoo.comOndine Biomedical Inc. (OBI.L)November 6, 2023 | finance.yahoo.comOndine Biomedical’s Steriwave platform seeing strong adoptionOctober 31, 2023 | uk.movies.yahoo.comOndine Biomedical Inc Announces Steriwave use Expanded Following Successful PilotOctober 27, 2023 | lse.co.ukOndine Biomed Regulatory NewsOctober 13, 2023 | uk.style.yahoo.comOndine Biomedical Inc. - Steriwave now in Canada's East CoastOctober 13, 2023 | proactiveinvestors.comOndine Biomedical share price soars after Canadian hospital adopts SteriwaveOctober 6, 2023 | investing.comOndine Biomedical Inc (OBI)September 29, 2023 | uk.finance.yahoo.comOndine Biomedical Inc. Announces Burnaby Hospital deploys SteriwaveSeptember 21, 2023 | uk.style.yahoo.comOndine Biomedical Inc. Announces Montreal Heart Institute pilots SteriwaveSeptember 20, 2023 | finance.yahoo.comOndine’s nasal photodisinfection therapy (APDT) improves short-term and long-term immune response while significantly reducing SARS-CoV-2 infectivitySee More Headlines Receive OBI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Ondine Biomedical and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolLON:OBI CUSIPN/A CIKN/A Webwww.ondinebio.com Phone604-669-0555FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)GBX (0.06) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income£-18,700,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-144.07% Return on Assets-70.25% Debt Debt-to-Equity Ratio24.39 Current Ratio2.34 Quick Ratio8.26 Sales & Book Value Annual Sales£856,000.00 Price / Sales24.30 Cash FlowGBX 3.77 per share Price / Cash Flow1.99 Book ValueGBX 2 per share Price / Book3.75Miscellaneous Outstanding Shares277,290,000Free FloatN/AMarket Cap£20.80 million OptionableNot Optionable Beta-0.01 7 Stocks to Buy And Hold ForeverClick the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free Report Key ExecutivesMs. Carolyn M. Cross C.F.A.CFA, M.B.A., MBA, Founder, CEO & Executive DirectorDr. Nicolas G. Loebel Ph.D.President, CTO & Executive DirectorDr. Simon Sinclair Ph.D. (Age 52)Chief Medical Officer & Director Comp: $71.85kMr. Kwong Choo CPACIMA, Interim Chief Financial OfficerMr. William KanzSenior VP of Engineering & OperationsAngelika VanceVice President of Corporate CommunicationsMr. Matt RossVice President of Sales & MarketingMs. Elaine Lei CPACorporate ControllerMore ExecutivesKey CompetitorsPoolbeg PharmaLON:POLBFaron Pharmaceuticals OyLON:FARNOpen OrphanLON:ORPHRedx PharmaLON:REDXe-therapeuticsLON:ETXView All Competitors OBI Stock Analysis - Frequently Asked Questions How have OBI shares performed in 2024? Ondine Biomedical's stock was trading at GBX 8.75 at the beginning of the year. Since then, OBI shares have decreased by 14.3% and is now trading at GBX 7.50. View the best growth stocks for 2024 here. How do I buy shares of Ondine Biomedical? Shares of OBI stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. This page (LON:OBI) was last updated on 6/13/2024 by MarketBeat.com Staff From Our PartnersNvidia is now part of $3 Trillion Market Cap ClubA small handful of Nvidia’s partners could see their own stocks surge upwards. They’re virtually unknown ri...Weiss Ratings | SponsoredGold Prices Surge and This $0.32 Stock Is Reaping The RewardsGold prices are on the rise. This surge in gold prices is great news for gold mining stocks. Especially ...Market JAR | SponsoredEstee Lauder, MAC, and other beauty brands are raving about this emerging NYSE AI companyA Little-known NYSE Company is Empowering the Beauty Industry with Innovative AI and AR Tools.Financial Markets Daily | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredThe Only Energy Play You Should Be Looking AtOpen AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...Wealthpin Pro | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ondine Biomedical Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Ondine Biomedical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.